Liver cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.>=18 years old. 2. Patients diagnosed with primary hepatocellular carcinoma pathologically. 3. The patient did not receive chemoradiotherapy, immunotherapy or targeted therapy before surgery. 4. Liver MR enhancement or abdominal CT enhancement were completed within 1 month before surgery. 5. Volunteer to participate in this study and sign the informed consent form. If the subject is unable to read and sign the informed consent form due to incapacity or other reasons, his or her guardian must represent the informed process and sign the informed consent form. If the subject is unable to read the informed consent form (e.g., illiterate subject), a witness must witness the informed process and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with incomplete clinical data. 2. Complicated with tumors in other locations. 3. Family history of cancer. 4. The quality of preoperative imaging data was poor. 5. Vulnerable groups, including people with mental illness, people with cognitive impairment, critically ill patients, pregnant women, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative Overall survival;Postoperative Disease survival; | — |
Countries
China
Contacts
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology